Search This Blog

Tuesday, February 5, 2019

Haemonetics backs FY19 adj. EPS view of $2.25-$2.35, consensus $2.33

Backs FY19 revenue guidance of up 6%-8%. Raises FY19 cash flow from operating activities guidance to $160M-$185M from $150M-$175M.
https://thefly.com/landingPageNews.php?id=2858851
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)